Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gail A Hecht

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
American Journal of Physiology. Gastrointestinal and Liver Physiology|March 10, 2012
Enteropathogenic Escherichia coli inhibits ileal sodium-dependent bile acid transporter ASBTFadi Annaba, Zaheer Sarwar, Ravinder K Gill, et al.
Gastroenterology|September 15, 2009
Enteropathogenic Escherichia coli infection inhibits intestinal serotonin transporter function and expressionAli Esmaili, Saad F Nazir, Alip Borthakur, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 24, 2013
What is the value of a food and drug administration investigational new drug application for fecal microbiota transplantation to treat Clostridium difficile Infection?Gail A Hecht, Martin J Blaser, Jeffrey Gordon, et al.
Gastrointestinal Endoscopy|November 26, 2002
National Institutes of Health State-of-the-Science Conference Statement: ERCP for diagnosis and therapy, January 14-16, 2002Sidney Cohen, Bruce R Bacon, Jesse A Berlin, et al.
Molecular Microbiology|November 25, 2010
Enteropathogenic E. coli non-LEE encoded effectors NleH1 and NleH2 attenuate NF-κB activationSandhya V Royan, Rheinallt M Jones, Athanasia Koutsouris, et al.
The Journal of Cell Biology|September 26, 2007
The type III effector EspF coordinates membrane trafficking by the spatiotemporal activation of two eukaryotic signaling pathwaysNeal M Alto, Andrew W Weflen, Matthew J Rardin, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
American Journal of Physiology. Gastrointestinal and Liver Physiology|March 10, 2012
Enteropathogenic Escherichia coli inhibits ileal sodium-dependent bile acid transporter ASBTFadi Annaba, Zaheer Sarwar, Ravinder K Gill, et al.
Gastroenterology|September 15, 2009
Enteropathogenic Escherichia coli infection inhibits intestinal serotonin transporter function and expressionAli Esmaili, Saad F Nazir, Alip Borthakur, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 24, 2013
What is the value of a food and drug administration investigational new drug application for fecal microbiota transplantation to treat Clostridium difficile Infection?Gail A Hecht, Martin J Blaser, Jeffrey Gordon, et al.
Gastrointestinal Endoscopy|November 26, 2002
National Institutes of Health State-of-the-Science Conference Statement: ERCP for diagnosis and therapy, January 14-16, 2002Sidney Cohen, Bruce R Bacon, Jesse A Berlin, et al.
Molecular Microbiology|November 25, 2010
Enteropathogenic E. coli non-LEE encoded effectors NleH1 and NleH2 attenuate NF-κB activationSandhya V Royan, Rheinallt M Jones, Athanasia Koutsouris, et al.
The Journal of Cell Biology|September 26, 2007
The type III effector EspF coordinates membrane trafficking by the spatiotemporal activation of two eukaryotic signaling pathwaysNeal M Alto, Andrew W Weflen, Matthew J Rardin, et al.
Pageof 4